| Names | |
|---|---|
|
IUPAC name
8-(2,3-Dihydro-1,4-benzodioxin-2-ylmethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one
|
|
| Identifiers | |
|
3D model (Jmol)
|
|
| ChemSpider | |
| MeSH | Spiroxatrine |
|
PubChem CID
|
|
| UNII | |
|
|
|
|
| Properties | |
| C22H25N3O3 | |
| Molar mass | 379.46 g·mol−1 |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
|
|
|
| Infobox references | |
Spiroxatrine is a drug which acts as a selective antagonist at both the 5-HT1A receptor and the α2C adrenergic receptor. It is an analog of spiperone and also has some dopamine antagonist effects.